Clinical Trial Update: A Study Comparing Two Forms of Didanosine in HIV-infected Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing two formulations of didanosine in HIV-infected patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Videx (didanosine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1 | Status: COMPLETED